What is Corteva Inc's earnings per share (EPS)?

Corteva Inc (CTVA) reported diluted earnings per share of $1.60 for fiscal year 2025. This represents a 23.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Corteva Inc Financials

CTVA

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Corteva Inc (CTVA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CTVA FY2025 2026-04-22

Margin expansion, disciplined balance-sheet use, and light reinvestment needs turned mostly steady sales into much stronger cash output.

From FY2022 to FY2025, gross margin expansion from 40.2% to 47.3% happened while sales stayed broadly flat, so the recovery was not mainly a top-line story. Free cash flow climbed from $267M to $2.8B, implying better unit economics plus easier working capital rather than simple volume growth.

Corteva's balance sheet looks internally funded: cash of $4.5B comfortably exceeds long-term debt of $1.7B. That matters because the company still returned over $1.5B through buybacks and dividends in FY2025 without pushing leverage higher, which suggests capital returns are being supported by operations rather than by stretching the balance sheet.

The business is also not especially capital intensive: capex stayed near $600M while operating cash flow reached $3.4B in FY2025. Because R&D rose to $1.5B and SG&A also increased, the improvement at the gross-profit level is what funds reinvestment, a useful sign that expense growth is not swallowing the gains from a better cost structure.

Financial Health Signals

Financial Profile 39/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Corteva Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Growth

Corteva Inc's revenue grew a modest 2.9% year-over-year to $17.4B. This slow but positive growth earns a score of 34/100.

Leverage

100

Corteva Inc carries a low D/E ratio of 0.07, meaning only $0.07 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Corteva Inc's current ratio of 1.43 is below the typical benchmark, resulting in a score of 24/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Corteva Inc has a free cash flow margin of 16.2%, earning a moderate score of 56/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Corteva Inc generates a 4.5% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 20/100. This is up from 3.8% the prior year.

Piotroski F-Score Strong

7/9

Corteva Inc passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.11x

For every $1 of reported earnings, Corteva Inc generates $3.11 in operating cash flow ($3.4B OCF vs $1.1B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$17.4B

YoY+2.9%

5Y CAGR+4.1%

Corteva Inc generated $17.4B in revenue in fiscal year 2025. This represents an increase of 2.9% from the prior year.

EBITDA

N/A

Net Income

$1.1B

YoY+20.6%

5Y CAGR+9.9%

Corteva Inc reported $1.1B in net income in fiscal year 2025. This represents an increase of 20.6% from the prior year.

EPS (Diluted)

$1.60

YoY+23.1%

5Y CAGR+11.9%

Corteva Inc earned $1.60 per diluted share (EPS) in fiscal year 2025. This represents an increase of 23.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$2.8B

YoY+81.8%

5Y CAGR+12.1%

Corteva Inc generated $2.8B in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 81.8% from the prior year.

Cash & Debt

$4.5B

YoY+45.6%

5Y CAGR+5.1%

Corteva Inc held $4.5B in cash against $1.7B in long-term debt as of fiscal year 2025.

Dividends Per Share

$0.70

YoY+6.1%

5Y CAGR+6.1%

Corteva Inc paid $0.70 per share in dividends in fiscal year 2025. This represents an increase of 6.1% from the prior year.

Shares Outstanding

673M

YoY-1.9%

5Y CAGR-2.0%

Corteva Inc had 673M shares outstanding in fiscal year 2025. This represents a decrease of 1.9% from the prior year.

Margins & Returns

Gross Margin

47.3%

YoY+3.6pp

5Y CAGR+7.1pp

Corteva Inc's gross margin was 47.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 3.6 percentage points from the prior year.

Operating Margin

N/A

Net Margin

6.3%

YoY+0.9pp

5Y CAGR+1.5pp

Corteva Inc's net profit margin was 6.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 0.9 percentage points from the prior year.

Return on Equity

4.5%

YoY+0.7pp

5Y CAGR+1.8pp

Corteva Inc's ROE was 4.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 0.7 percentage points from the prior year.

Capital Allocation

R&D Spending

$1.5B

YoY+5.1%

5Y CAGR+5.2%

Corteva Inc invested $1.5B in research and development in fiscal year 2025. This represents an increase of 5.1% from the prior year.

Share Buybacks

$1.1B

YoY+6.1%

5Y CAGR+31.2%

Corteva Inc spent $1.1B on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 6.1% from the prior year.

Capital Expenditures

$591.0M

YoY-1.0%

5Y CAGR+4.5%

Corteva Inc invested $591.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 1.0% from the prior year.

CTVA Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$17.4B+2.9%	$16.9B-1.8%	$17.2B-1.3%	$17.5B+11.5%	$15.7B+10.1%	$14.2B
Cost of Revenue	$9.2B-3.7%	$9.5B-3.9%	$9.9B-4.9%	$10.4B+13.2%	$9.2B+8.4%	$8.5B
Gross Profit	$8.2B+11.5%	$7.4B+1.0%	$7.3B+4.1%	$7.0B+9.1%	$6.4B+12.7%	$5.7B
R&D Expenses	$1.5B+5.1%	$1.4B+4.9%	$1.3B+10.0%	$1.2B+2.4%	$1.2B+3.9%	$1.1B
SG&A Expenses	$3.5B+9.3%	$3.2B+0.6%	$3.2B+0.1%	$3.2B-1.1%	$3.2B+5.5%	$3.0B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$180.0M-22.7%	$233.0M0.0%	$233.0M+194.9%	$79.0M+163.3%	$30.0M-33.3%	$45.0M
Income Tax	$484.0M+17.5%	$412.0M+171.1%	$152.0M-27.6%	$210.0M-59.9%	$524.0M+746.9%	-$81.0M
Net Income	$1.1B+20.6%	$907.0M+23.4%	$735.0M-35.9%	$1.1B-34.8%	$1.8B+158.3%	$681.0M
EPS (Diluted)	$1.60+23.1%	$1.30+26.2%	$1.03-34.8%	$1.58-33.3%	$2.37+160.4%	$0.91

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$4.9B+25.4%	$3.9B+49.4%	$2.6B-59.4%	$6.5B+46.2%	$4.4B+11.0%	$4.0B+71.0%	$2.3B-61.9%	$6.1B
Cost of Revenue	$2.4B+5.2%	$2.3B+37.1%	$1.6B-43.9%	$2.9B+25.2%	$2.3B-6.2%	$2.5B+59.5%	$1.6B-46.4%	$2.9B
Gross Profit	$2.5B+53.0%	$1.7B+70.0%	$974.0M-72.4%	$3.5B+69.8%	$2.1B+40.0%	$1.5B+94.7%	$761.0M-76.2%	$3.2B
R&D Expenses	$341.0M-17.4%	$413.0M+17.7%	$351.0M-6.4%	$375.0M+11.9%	$335.0M-8.2%	$365.0M+4.9%	$348.0M-2.5%	$357.0M
SG&A Expenses	$877.0M+2.0%	$860.0M+18.6%	$725.0M-37.3%	$1.2B+53.9%	$751.0M+2.2%	$735.0M+9.5%	$671.0M-36.3%	$1.1B
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$36.0M	N/A	N/A	$52.0M+44.4%	$36.0M-40.0%	$60.0M-9.1%	$66.0M0.0%	$66.0M
Income Tax	$133.0M+1800.0%	$7.0M+111.3%	-$62.0M-114.7%	$422.0M+260.7%	$117.0M-15.2%	$138.0M+221.1%	-$114.0M-140.4%	$282.0M
Net Income	$720.0M+230.4%	-$552.0M-72.5%	-$320.0M-124.4%	$1.3B+101.5%	$652.0M+1690.2%	-$41.0M+92.2%	-$524.0M-149.8%	$1.1B
EPS (Diluted)	$1.07	N/A	$-0.47-124.5%	$1.92+102.1%	$0.95	N/A	$-0.76-150.3%	$1.51

CTVA Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$42.8B+4.9%	$40.8B-5.0%	$43.0B+0.9%	$42.6B+0.6%	$42.3B-0.7%	$42.6B
Current Assets	$17.3B+14.8%	$15.1B-7.2%	$16.3B-3.2%	$16.8B+8.0%	$15.5B+5.3%	$14.8B
Cash & Equivalents	$4.5B+45.6%	$3.1B+17.5%	$2.6B-17.1%	$3.2B-28.4%	$4.5B+26.5%	$3.5B
Inventory	$5.7B+4.3%	$5.4B-21.3%	$6.9B+1.3%	$6.8B+31.5%	$5.2B+6.1%	$4.9B
Accounts Receivable	$4.9B+9.7%	$4.4B+5.7%	$4.2B+1.0%	$4.2B+21.1%	$3.4B-8.3%	$3.8B
Goodwill	$10.5B+0.5%	$10.4B-1.9%	$10.6B+6.5%	$10.0B-1.4%	$10.1B-1.6%	$10.3B
Total Liabilities	$18.7B+9.8%	$17.0B-5.1%	$18.0B+3.7%	$17.3B+2.1%	$17.0B-4.9%	$17.8B
Current Liabilities	$12.1B+16.7%	$10.4B-0.2%	$10.4B-3.1%	$10.7B+12.4%	$9.6B+11.8%	$8.5B
Long-Term Debt	$1.7B-13.7%	$2.0B-14.8%	$2.3B+78.6%	$1.3B+16.6%	$1.1B-0.2%	$1.1B
Total Equity	$24.1B+1.5%	$23.8B-5.0%	$25.0B-1.0%	$25.3B-0.3%	$25.4B+2.3%	$24.8B
Retained Earnings	-$67.0M-221.8%	$55.0M+234.1%	-$41.0M-116.4%	$250.0M-52.3%	$524.0M	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$42.7B-0.3%	$42.8B+1.5%	$42.2B+1.1%	$41.8B-0.9%	$42.1B+3.2%	$40.8B-2.6%	$41.9B+1.1%	$41.5B
Current Assets	$17.4B+0.3%	$17.3B+5.5%	$16.4B+2.7%	$16.0B-3.5%	$16.6B+9.9%	$15.1B-3.5%	$15.6B+1.9%	$15.4B
Cash & Equivalents	$2.0B-56.6%	$4.5B+80.2%	$2.5B+21.5%	$2.1B+2.8%	$2.0B-35.4%	$3.1B+28.3%	$2.4B+31.6%	$1.8B
Inventory	$5.2B-8.2%	$5.7B+6.7%	$5.3B+23.0%	$4.3B-15.9%	$5.1B-5.5%	$5.4B-4.3%	$5.7B+16.0%	$4.9B
Accounts Receivable	$7.3B+48.8%	$4.9B-3.3%	$5.0B-15.3%	$6.0B-11.9%	$6.8B+52.1%	$4.4B+4.4%	$4.3B-17.6%	$5.2B
Goodwill	$10.4B-0.5%	$10.5B-0.4%	$10.5B-0.1%	$10.5B+1.8%	$10.3B-0.7%	$10.4B-2.1%	$10.6B+1.3%	$10.5B
Total Liabilities	$18.4B-1.9%	$18.7B+10.1%	$17.0B+7.1%	$15.8B-11.1%	$17.8B+4.7%	$17.0B-0.8%	$17.2B+5.4%	$16.3B
Current Liabilities	$11.9B-2.2%	$12.1B+16.4%	$10.4B+9.5%	$9.5B-17.1%	$11.5B+10.5%	$10.4B-0.4%	$10.4B+16.4%	$9.0B
Long-Term Debt	$1.7B-0.2%	$1.7B-0.1%	$1.7B+0.1%	$1.7B-5.9%	$1.8B-8.2%	$2.0B-1.1%	$2.0B-20.1%	$2.5B
Total Equity	$24.4B+0.9%	$24.1B-4.3%	$25.2B-2.7%	$25.9B+6.7%	$24.3B+2.1%	$23.8B-3.8%	$24.7B-1.8%	$25.2B
Retained Earnings	$436.0M+750.7%	-$67.0M-108.0%	$834.0M-45.6%	$1.5B+161.0%	$587.0M+967.3%	$55.0M-43.9%	$98.0M-90.1%	$992.0M

CTVA Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.4B+58.8%	$2.1B+21.3%	$1.8B+102.9%	$872.0M-68.0%	$2.7B+32.1%	$2.1B
Capital Expenditures	$591.0M-1.0%	$597.0M+0.3%	$595.0M-1.7%	$605.0M+5.6%	$573.0M+20.6%	$475.0M
Free Cash Flow	$2.8B+81.8%	$1.5B+31.9%	$1.2B+339.7%	$267.0M-87.6%	$2.2B+35.6%	$1.6B
Investing Cash Flow	-$543.0M+7.8%	-$589.0M+70.4%	-$2.0B-214.4%	-$632.0M-74.6%	-$362.0M+46.3%	-$674.0M
Financing Cash Flow	-$1.6B-37.1%	-$1.2B-1111.1%	-$99.0M+91.6%	-$1.2B+6.8%	-$1.3B-517.8%	$303.0M
Dividends Paid	$475.0M+3.7%	$458.0M+4.3%	$439.0M+5.0%	$418.0M+5.3%	$397.0M+202.3%	-$388.0M
Share Buybacks	$1.1B+6.1%	$1.0B+33.5%	$756.0M-24.4%	$1.0B+5.3%	$950.0M+245.5%	$275.0M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$2.9B-166.1%	$4.4B+2166.8%	$193.0M-79.6%	$947.0M+144.9%	-$2.1B-150.5%	$4.2B+3110.0%	$130.0M-71.2%	$451.0M
Capital Expenditures	$81.0M-63.5%	$222.0M+41.4%	$157.0M+33.1%	$118.0M+25.5%	$94.0M-48.1%	$181.0M+17.5%	$154.0M+35.1%	$114.0M
Free Cash Flow	-$3.0B-171.6%	$4.2B+11436.1%	$36.0M-95.7%	$829.0M+137.6%	-$2.2B-155.2%	$4.0B+16733.3%	-$24.0M-107.1%	$337.0M
Investing Cash Flow	-$77.0M+59.0%	-$188.0M-19.7%	-$157.0M+4.3%	-$164.0M-382.4%	-$34.0M+72.4%	-$123.0M+23.6%	-$161.0M-360.0%	-$35.0M
Financing Cash Flow	$389.0M+117.7%	-$2.2B-698.9%	$367.0M+145.4%	-$808.0M-181.2%	$995.0M+129.8%	-$3.3B-638.9%	$619.0M+349.6%	-$248.0M
Dividends Paid	$121.0M0.0%	$121.0M-0.8%	$122.0M+5.2%	$116.0M0.0%	$116.0M-1.7%	$118.0M+0.9%	$117.0M+5.4%	$111.0M
Share Buybacks	$250.0M-16.9%	$301.0M+20.4%	$250.0M0.0%	$250.0M-7.4%	$270.0M+7.1%	$252.0M-0.4%	$253.0M+0.4%	$252.0M

CTVA Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	47.3%+3.6pp	43.6%+1.2pp	42.4%+2.2pp	40.2%-0.9pp	41.1%+1.0pp	40.2%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	6.3%+0.9pp	5.4%+1.1pp	4.3%-2.3pp	6.6%-4.7pp	11.2%+6.5pp	4.8%
Return on Equity	4.5%+0.7pp	3.8%+0.9pp	2.9%-1.6pp	4.5%-2.4pp	6.9%+4.2pp	2.7%
Return on Assets	2.5%+0.3pp	2.2%+0.5pp	1.7%-1.0pp	2.7%-1.5pp	4.2%+2.6pp	1.6%
Current Ratio	1.43-0.0	1.45-0.1	1.560.0	1.56-0.1	1.63-0.1	1.73
Debt-to-Equity	0.07-0.0	0.080.0	0.09+0.0	0.050.0	0.040.0	0.04
FCF Margin	16.2%+7.0pp	9.2%+2.3pp	6.8%+5.3pp	1.5%-12.2pp	13.8%+2.6pp	11.2%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	51.6%+9.3pp	42.4%+5.1pp	37.2%-17.4pp	54.6%+7.6pp	47.0%+9.7pp	37.3%+4.5pp	32.7%-19.5pp	52.3%
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	14.7%+28.8pp	-14.1%-1.9pp	-12.2%-32.6pp	20.3%+5.6pp	14.8%+15.8pp	-1.0%+21.5pp	-22.5%-39.8pp	17.2%
Return on Equity	3.0%+5.2pp	-2.3%-1.0pp	-1.3%-6.3pp	5.1%+2.4pp	2.7%+2.9pp	-0.2%+1.9pp	-2.1%-6.3pp	4.2%
Return on Assets	1.7%+3.0pp	-1.3%-0.5pp	-0.8%-3.9pp	3.1%+1.6pp	1.6%+1.7pp	-0.1%+1.1pp	-1.3%-3.8pp	2.5%
Current Ratio	1.47+0.0	1.43-0.1	1.58-0.1	1.68+0.2	1.440.0	1.45-0.0	1.50-0.2	1.72
Debt-to-Equity	0.070.0	0.070.0	0.070.0	0.070.0	0.070.0	0.080.0	0.08-0.0	0.10
FCF Margin	-60.6%-166.8pp	106.2%+104.8pp	1.4%-11.5pp	12.8%+62.7pp	-49.9%-150.2pp	100.4%+101.4pp	-1.0%-6.5pp	5.5%

Similar Companies

$33.4B

$17.9B

$7.6B

$8.7B

$1.7B

Frequently Asked Questions

What is Corteva Inc's annual revenue?

Corteva Inc (CTVA) reported $17.4B in total revenue for fiscal year 2025. This represents a 2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Corteva Inc's revenue growing?

Corteva Inc (CTVA) revenue grew by 2.9% year-over-year, from $16.9B to $17.4B in fiscal year 2025.

Is Corteva Inc profitable?

Yes, Corteva Inc (CTVA) reported a net income of $1.1B in fiscal year 2025, with a net profit margin of 6.3%.

How much debt does Corteva Inc have?

As of fiscal year 2025, Corteva Inc (CTVA) had $4.5B in cash and equivalents against $1.7B in long-term debt.

What is Corteva Inc's gross margin?

Corteva Inc (CTVA) had a gross margin of 47.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Corteva Inc's net profit margin?

Corteva Inc (CTVA) had a net profit margin of 6.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Corteva Inc pay dividends?

Yes, Corteva Inc (CTVA) paid $0.70 per share in dividends during fiscal year 2025.

What is Corteva Inc's return on equity (ROE)?

Corteva Inc (CTVA) has a return on equity of 4.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Corteva Inc's free cash flow?

Corteva Inc (CTVA) generated $2.8B in free cash flow during fiscal year 2025. This represents a 81.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Corteva Inc's operating cash flow?

Corteva Inc (CTVA) generated $3.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Corteva Inc's total assets?

Corteva Inc (CTVA) had $42.8B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Corteva Inc's capital expenditures?

Corteva Inc (CTVA) invested $591.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Corteva Inc spend on research and development?

Corteva Inc (CTVA) invested $1.5B in research and development during fiscal year 2025.

Does Corteva Inc buy back shares?

Yes, Corteva Inc (CTVA) spent $1.1B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Corteva Inc have outstanding?

Corteva Inc (CTVA) had 673M shares outstanding as of fiscal year 2025.

What is Corteva Inc's current ratio?

Corteva Inc (CTVA) had a current ratio of 1.43 as of fiscal year 2025, which is considered adequate.

What is Corteva Inc's debt-to-equity ratio?

Corteva Inc (CTVA) had a debt-to-equity ratio of 0.07 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Corteva Inc's return on assets (ROA)?

Corteva Inc (CTVA) had a return on assets of 2.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Corteva Inc's Piotroski F-Score?

Corteva Inc (CTVA) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Corteva Inc's earnings high quality?

Corteva Inc (CTVA) has an earnings quality ratio of 3.11x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Corteva Inc?

Corteva Inc (CTVA) scores 39 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.